The Thioredoxin System of Mammalian Cells and Its Modulators.
Level 5 - mechanism / opinion, no new human data
Narrative review of biochemical mechanisms with no original human trial data
PubMed 35885063 · doi:10.3390/biomedicines10071757
What was done
The authors reviewed published literature on the mammalian thioredoxin and thioredoxin reductase (Trx/TrxR) antioxidant system. The review outlines the structural and catalytic features of Trx/TrxR, its NADPH-dependent thiol-disulfide exchange mechanisms, its role in cellular signaling alongside other pathways such as the glutathione system, and the factors that modulate Trx activity.
What was found
The abstract provides no quantitative findings, effect estimates, or numerical data. It qualitatively describes the Trx/TrxR system as a regulator of redox balance, cell proliferation, and survival, and notes its application as a therapeutic target in cancer.
Why it matters
This paper consolidates mechanistic knowledge on how the thioredoxin pathway manages oxidative stress and highlights strategies for pharmacologically targeting redox balance in diseases such as cancer.
Limits
This is a narrative review with no systematic search methodology, meta-analytic data, or new primary empirical measurements reported in the abstract. Clinical efficacy and safety of specific modulators are not quantified.
Cited by
- supports The detoxification of reactive oxygen species in cells is dependent on NADPH.